Monocarboxylate transporter-1 (MCT1) protein expression in head and neck cancer affects clinical outcome

Treatment of locally advanced, unresectable head and neck squamous cell carcinoma (HNSCC) often yields only modest results with radiochemotherapy (RCT) as standard of care. Prognostic features related to outcome upon RCT might be highly valuable to improve treatment. Monocarboxylate transporters-1 a...

Descripción completa

Detalles Bibliográficos
Autores principales: Leu, Martin, Kitz, J., Pilavakis, Y., Hakroush, S., Wolff, H. A., Canis, M., Rieken, S., Schirmer, M. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7907348/
https://www.ncbi.nlm.nih.gov/pubmed/33633176
http://dx.doi.org/10.1038/s41598-021-84019-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7907348/
https://www.ncbi.nlm.nih.gov/pubmed/33633176
http://dx.doi.org/10.1038/s41598-021-84019-w

Ejemplares similares